On Thursday, May 4, 2006, the New Hampshire Senate passed HB 1346 to ban the sale of information that identifies a specific prescriber or patient on a prescription. The measure has already passed the House and will be the first bill of its kind to become law.
Pharma Marketing News hosted the Pharma Use of Rx Data Survey in June, 2006 and asked respondents to weigh in on several issues regarding the collection and use of Rx data by pharmaceutical companies. This article summarizes the results of that survey.
Topics covered include:
- Does the use of Rx data by pharmaceutical companies make marketing more relevant and cost-effective?
- Does the use of Rx data allow pharmaceutical companies to more quickly notify physicians of product recalls?
- Other Uses of Rx Data
- The Far Flung Influence of the Pharma Industry
Read this article now. It's FREE...
Download PDF file